Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jul 17, 2019
Date Accepted: Dec 10, 2019
Awareness Development and Usage of mobile Health Technology among Individuals with Hypertension in a Rural Community of Bangladesh: A Randomized Controlled Trial Study Protocol
ABSTRACT
Background:
Hypertension (HTN) remains one of the foremost non-communicable diseases (NCDs) that most often lead individuals towards cardiovascular diseases (CVDs) and its different complications such as stroke, kidney failure, disability, and even premature death. The prevalence of HTN in Bangladesh is showing an increasing trend. However, there are very limited studies that evaluated the impact of health education or awareness development to mitigate the burden of HTN and its complications in Bangladesh.
Objective:
In this study, we aim to improve awareness, enrich knowledge and make behavioral modifications by using health education and mobile Health (mHealth) technology among individuals with HTN living in a rural community of Bangladesh.
Methods:
A randomized controlled trial is being conducted in a rural community of Mirzapur, Bangladesh comparing two groups of individuals with HTN, one group receiving (i) standard-of-care representing comparison arm and the other group getting (ii) standard-of-care plus a periodic mobile phone-based text message comprising intervention arm. The total study duration is 12 months.
Results:
The enrollment of participants started in August 2018, and follow-up will be completed in July 2019. Four hundred twenty participants volunteered to participate and among them 209 and 211 were randomly allocated into the intervention group and the control group, respectively. Data cleaning and analyses have partially begun as of the time this article is submitted.
Conclusions:
It is expected that mHealth technology may be an effective tool for providing HTN-related health education, reminding health check-up, drug and instruction compliance, thus enhance self-confidence in management of HTN at the household level. Clinical Trial: This study has been approved by Bangladesh Medical Research council (BMRC), Registration # 06025072017, Clinical Trial Registration # NCT03614104, and UMIN # R000033736.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.